IMNN (Imunon) Earnings per share for the trailing year

Public company logo of Imunon, Inc. (IMNN)

The rolling year net income per share dynamics for Imunon, Inc. (IMNN) reflect the impact of logistical risks and patent disputes with Asia. Now 68.10 becomes the new value for this metric. Flexibility is maintained through the outsourcing of production and testing to external partners. Growth prospects are based on the development of innovative DNA-based drugs to combat infections and oncology.

IMNN Imunon Inc: Earnings per share for the last twelve months in the range 02/11/2024 - 11/17/2026

Financial and market metric breakdowns for Imunon Inc (IMNN)

- share price and consensus valuation forecast:
- business market valuation indicators:
Fundamental company valuation:IMNN (Celsion Corporation)
Manufactured product of Imunon

For Imunon, Inc. (IMNN), whose market capitalization depends on the success of clinical trials within the cancer immunotherapy niche, this metric serves as an indicator of actual business efficiency. By analyzing the year-over-year (YoY) percentage growth of earnings per share over 12 months on the GURU.Markets platform, an investor assesses the annual net income trend, which allows them to filter out short-term volatility and avoid overpaying for the asset.

Competitor analysis

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Net earnings per share (EPS TTM)|proqr.com (PRQR) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CDXS (Codexis Bio)|SGMO - Net earnings per one share for the last twelve months|Nautilus Biotechnology, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Metagenomi, Inc|Precision BioSciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Earnings per share for the last twelve months|Exicure Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months RXi Pharmaceuticals|Net earnings per share (EPS TTM) mustangbio.com|Net earnings per share (EPS TTM) RNAZ|Earnings per share for the last twelve months BNGO (Bionano Genomics)|Earnings per share for the last twelve months Applied DNA Sciences APDN|Net earnings per share for the last four quarters bluebird bio Inc. (BLUE)|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX